30 April 2021 - In an historic first, Australians living with a rare form of epilepsy will have access to a medicinal cannabis drug, which is being listed on Australia’s PBS for the first time.
From 1 May 2021, Australians living with Dravet syndrome, will have access to Epidyolex (cannabidiol), a new treatment used in combination with at least two other anti-epileptic medicines on the PBS.